TLR3 and rheumatoid arthritis: Cell culture studies with TLR-3, 7, 8, and 9 inhibitors resulted in reduced levels of inflammatory cytokines (TNFα and IL-6), while agonists significantly increased the secretion of such molecules, suggesting that a viral infection or an endogenous ligand can potentially trigger the chronic inflammation in RA patients [38].